KEVIN D FREEMAN
CIK 1522478 · last filed 2026-01-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$361.2K
Companies
2
Total Filings
51
Lifetime Open-Market Net
$389.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GALT | Director | 135,269 | $2.67 | $361.2K | $368.6K | 42 | 2026-01-21 |
| GALECTIN THERAPEUTICS INC (GALTW) Delisted | Director | 29,726 | — | — | $20.6K | 7 | 2016-12-19 |
Recent Filings · Page 3 of 6
51 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-12-15 | GALT | Buy (P) | +5,000 | $11.4K | EDGAR |
| 2021-12-15 | GALT | Buy (P) | +5,000 | $11.4K | EDGAR |
| 2021-12-06 | GALT | Buy (P) | +5,000 | $11.7K | EDGAR |
| 2021-11-01 | GALT | Buy (P) | +2,000 | $6.3K | EDGAR |
| 2021-10-21 | GALT | Buy (P) | +2,000 | $6.4K | EDGAR |
| 2021-10-19 | GALT | Buy (P) | +3,000 | $10.1K | EDGAR |
| 2021-09-23 | GALT | Buy (P) | +3,000 | $11.6K | EDGAR |
| 2021-04-06 | GALT | Buy (P) | +5,000 | $10.2K | EDGAR |
| 2021-03-29 | GALT | Grant (A) | — | $0 | EDGAR |
| 2020-09-09 | GALT | Buy (P) | +5,000 | $12.8K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.